GLP-1 Management
GLP-1 Management
Medically guided GLP‑1 weight loss
GLP‑1 management uses medications that mimic natural gut hormones to reduce appetite, improve blood sugar control, and support sustainable fat loss
After an initial consultation and lab work, your Aerwell provider confirms that a GLP‑1 medication is appropriate and screens for contraindications. A personalized dosing schedule is started at a low dose and gradually increased while you check in regularly (usually monthly) for side‑effect review, progress tracking, and lifestyle coaching.
Please note: All clients must complete an initial assessment to determine eligibility and access this protocol.
Long-Term Results
Structured GLP‑1 programs often include monthly medical oversight and regular body‑composition tracking for better long‑term outcomes.
Improved Blood Sugar
Patients using GLP‑1 medications commonly experience improved blood sugar control alongside weight reduction.
6mo
GLP‑1 programs under medical supervision have been associated with clinically significant weight loss over 6 mo. in many patients.
Targeted Fat Loss
Combining GLP‑1 therapy with body‑composition testing helps preserve lean mass while targeting fat loss.
GLP-1 agonists (e.g., semaglutide or tirzepatide) help manage weight, improve blood sugar control, and reduce appetite for sustainable fat loss.
Adults with elevated BMI, weight-related conditions, or challenges with traditional weight loss, after initial assessment and labs.
Clinical data shows average weight loss of 15–22% over several months, with benefits to metabolic health when combined with lifestyle guidance.
Mild gastrointestinal effects like nausea are possible initially; these often improve, and dosing is adjusted for comfort.